WHO Says Global Monkeypox Cases Have Jumped 77 Percent in One Week
Origin of the outbreak is still considered mysterious
Immunocompromised Hospitalized With COVID-19 Have Poor Outcomes
Immunocompromised patients have increased odds of ICU admission, in-hospital death, regardless of vaccination status
One in 13 U.S. Adults Report Long COVID Symptoms
Rates higher among younger adults and women, with some geographic variation
Resilience and Stress Management Program Aids Health Care Workers
Improvements seen in resilience, stress, anxiety, and burnout-exhaustion after the six-week program
FDA Allows Pharmacists to Prescribe COVID-19 Drug Paxlovid
However, patients who test positive for COVID-19 should still consider reaching out to their regular health care provider for Paxlovid first
Impact of Affiliation Mixed for Rural U.S. Hospitals
Benefits seen for financially distressed hospitals, but affiliation increases risk for closure among financially stable hospitals
Severe COVID-19 Rates Low With Monoclonal Antibody Therapy During Delta Surge
Rates of severe disease low for high-risk patients with mild-to-moderate COVID-19 treated with antispike monoclonal antibodies
COVID-19 Vaccination Greatly Reduced Morbidity, Mortality Burden in U.S.
Vaccination estimated to have prevented 52, 56, and 58 percent of expected infections, hospitalizations, deaths in adults from Sept. 1 to 30, 2021
Demographic, Clinical Characteristics of Monkeypox ID’d
Infection confirmed in 54 individuals, all of whom identified as men who have sex with men; all presented with skin lesions
Framework Issued for Developing Living Practice Guidelines
Framework addresses planning, production, reporting, and dissemination processes, as well as provides definitions
